Dishman Carbogen Amcis Limited (DCAL.BO)
INR 211.0
(0.12%)
INR 211.0
(0.12%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 8.82 Billion INR | 9.84% |
| 2022 | 8.03 Billion INR | 24.6% |
| 2021 | 6.45 Billion INR | 25.11% |
| 2020 | 5.15 Billion INR | -11.23% |
| 2019 | 5.8 Billion INR | 5.88% |
| 2018 | 5.48 Billion INR | 13.22% |
| 2017 | 4.84 Billion INR | 13.59% |
| 2016 | 4.26 Billion INR | -11.7% |
| 2015 | 4.83 Billion INR | 7.77% |
| 2014 | 4.48 Billion INR | 5.91% |
| 2013 | 4.23 Billion INR | 25.12% |
| 2012 | 3.38 Billion INR | 26.66% |
| 2011 | 2.67 Billion INR | -1.17% |
| 2010 | 2.7 Billion INR | 11.5% |
| 2009 | 2.42 Billion INR | -20.27% |
| 2008 | 3.03 Billion INR | -0.25% |
| 2007 | 3.04 Billion INR | 2.33% |
| 2006 | 2.97 Billion INR | 175.15% |
| 2005 | 1.08 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 8.82 Billion INR | 0.0% |
| 2023 Q2 | 8.51 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 8.82 Billion INR | 9.84% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 8.03 Billion INR | 24.6% |
| 2022 Q4 | 8.03 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 7.49 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 6.45 Billion INR | 25.11% |
| 2021 Q2 | 5.82 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 6.45 Billion INR | 0.0% |
| 2020 FY | 5.15 Billion INR | -11.23% |
| 2020 Q2 | 5.9 Billion INR | 0.0% |
| 2020 Q4 | 5.15 Billion INR | 0.0% |
| 2019 FY | 5.8 Billion INR | 5.88% |
| 2019 Q2 | 6.21 Billion INR | 0.0% |
| 2019 Q4 | 5.8 Billion INR | 0.0% |
| 2018 FY | 5.48 Billion INR | 13.22% |
| 2018 Q4 | 5.48 Billion INR | 0.0% |
| 2018 Q2 | 5.2 Billion INR | 0.0% |
| 2017 FY | 4.84 Billion INR | 13.59% |
| 2017 Q2 | 4.92 Billion INR | 0.0% |
| 2017 Q4 | 4.84 Billion INR | 0.0% |
| 2016 FY | 4.26 Billion INR | -11.7% |
| 2016 Q4 | 4.26 Billion INR | 0.0% |
| 2016 Q2 | 4.94 Billion INR | 0.0% |
| 2015 FY | 4.83 Billion INR | 7.77% |
| 2015 Q4 | 4.83 Billion INR | 0.0% |
| 2015 Q2 | 4.93 Billion INR | 0.0% |
| 2014 Q2 | 4.94 Billion INR | 0.0% |
| 2014 FY | 4.48 Billion INR | 5.91% |
| 2014 Q4 | 4.48 Billion INR | 0.0% |
| 2013 Q2 | 4.12 Billion INR | 0.0% |
| 2013 Q4 | 4.23 Billion INR | 0.0% |
| 2013 FY | 4.23 Billion INR | 25.12% |
| 2012 FY | 3.38 Billion INR | 26.66% |
| 2012 Q4 | 3.38 Billion INR | 0.0% |
| 2011 Q4 | 2.67 Billion INR | 0.0% |
| 2011 FY | 2.67 Billion INR | -1.17% |
| 2010 FY | 2.7 Billion INR | 11.5% |
| 2009 FY | 2.42 Billion INR | -20.27% |
| 2008 FY | 3.03 Billion INR | -0.25% |
| 2007 FY | 3.04 Billion INR | 2.33% |
| 2006 FY | 2.97 Billion INR | 175.15% |
| 2005 FY | 1.08 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | - INR | -Infinity% |
| Biocon Limited | 49.43 Billion INR | 82.142% |
| Blue Jet Healthcare Limited | 1.29 Billion INR | -580.009% |
| Concord Biotech Limited | 2.07 Billion INR | -324.561% |
| FERMENTA BIOTECH LIMITED | 890.74 Million INR | -891.18% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.00 INR | -882889999900.0% |
| Lyka Labs Limited | 95.71 Million INR | -9123.866% |
| Panacea Biotec Limited | 1.77 Billion INR | -396.173% |
| SAMSRITA LABS LIMITED | 1.00 INR | -882889999900.0% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 812.1 Million INR | -987.164% |
| Supriya Lifescience Limited | 852.49 Million INR | -935.66% |
| Syngene International Limited | 2.38 Billion INR | -270.184% |
| TAKE Solutions Limited | 7.96 Million INR | -110815.829% |
| Titan Biotech Limited | 455.71 Million INR | -1837.394% |
| Transgene Biotek Limited | 339 Thousand INR | -2604295.28% |
| Vanta Bioscience Limited | 75.2 Million INR | -11639.622% |